# Myeloperoxidase and Multi-Markers In the Diagnosis of Diagnoses of Acute Coronary Syndrome (MIDAS) - Sample Procurement

> **NCT00415948** · — · COMPLETED · sponsor: **Abbott RDx Cardiometabolic** · enrollment: 300 (estimated)

## Conditions studied

- Acute Coronary Syndrome (ACS)

## Interventions

- **DEVICE:** Biomarkers

## Key facts

- **NCT ID:** NCT00415948
- **Lead sponsor:** Abbott RDx Cardiometabolic
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2006-12
- **Primary completion:** —
- **Final completion:** 2008-06
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2009-12-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00415948

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00415948, "Myeloperoxidase and Multi-Markers In the Diagnosis of Diagnoses of Acute Coronary Syndrome (MIDAS) - Sample Procurement". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00415948. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*